The U.S. Food and Drug Administration calls Zepbound the first and only prescription medicine for adults with moderate-to-severe obstructive sleep apnea and obesity. The approval supports evidence ...

Study reveals that sleep traits predict over 15% of body characteristics across 15 physiological systems, with visceral fat, ...

Taking a GLP-1 may help treat sleep apnea since obesity is one of many factors that increases your likelihood of the sleep ...

Menopause is a significant phase in women's health, in which the incidence of obstructive sleep apnea (OSA) is significantly increased. Body fat distribution changes with age and hormone levels in ...

FDA 2025 pulmonology drug alerts, including drug approvals/warnings, vaccine approvals, and medical device recalls/updates.

The pathophysiology of residual sleepiness in treated obstructive sleep apnoea (OSA) remains poorly understood. Animal models ...

There are two types of sleep apnea: Obstructive sleep apnea (OSA) causes the upper airway to collapse briefly and temporarily pause breathing. The most common cause of obstructive apnea is obesity.

For instance, a septoplasty can fix a deviated septum that is reducing airflow, resulting in sleep apnea. Obstructive sleep apnea (OSA) occurs when any part of the airway from the tip of the nose to ...

The FDA approved the phase 2 Explore-OSA trial set to assess the highly selective aldosterone synthase inhibitor, lorundrostat, in adults with obstructive sleep apnea and hypertension, according to a ...

The two most commonly recognized types of sleep apnea are obstructive and central sleep ... cycles of reduced or stopped breathing (hypopnea) and increased breathing (hyperpnea).

Nearly 1 in 5 women and more than one-third of men in the United States have sleep apnea. This common sleep disorder causes you to stop breathing repeatedly in your sleep. It not only leaves you ...